Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.
Press releases published on July 29, 2025

Rakovina Therapeutics Announces Stock Option Grants
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug …

Firefly Awarded $177 Million NASA Contract for Mission to the Moon’s South Pole
CEDAR PARK, Texas, July 29, 2025 (GLOBE NEWSWIRE) -- Firefly Aerospace, a market leading space and defense technology company, was awarded a $176.7 million NASA Commercial Lunar Payload Services (CLPS) contract to deliver five NASA-sponsored payloads to …

Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
Residents of Portland now have exclusive access to a premier lineup of innovative aesthetic treatments designed to rejuvenate, refresh, and restore confidence. PORTLAND, OR, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- From cutting-edge anti-aging …

Kadant Reports Second Quarter 2025 Results
WESTFORD, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) reported its financial results for the second quarter ended June 28, 2025. Second Quarter Financial Highlights Bookings increased 7% to $269 million Revenue decreased 7% to $255 …

Vinmec Central Park Performs Vietnam’s First Pediatric SEEG with AutoGuide Robot
HO CHI MINH CITY, VIETNAM, July 29, 2025 /EINPresswire.com/ -- A major breakthrough in Vietnam’s neurological treatment was recently achieved as doctors at Vinmec Central Park International Hospital successfully performed surgery on a 9-year-old boy with …

Enovation in IOL Material: VSY Biotechnology’s Enova® Premium IOLs Set New Standard with 100% Glistening Free Technology
LEINFELDEN-ECHTERDINGEN, GERMANY, July 29, 2025 /EINPresswire.com/ -- VSY Biotechnology GmbH’s groundbreaking Enova® intraocular lens is reshaping expectations in the ophthalmic industry. As the first and only 100% glistening-free hydrophobic acrylic IOL …

Capital Power announces a 6% dividend increase for its common shares and declares dividends for its Preference shares
EDMONTON, Alberta, July 29, 2025 (GLOBE NEWSWIRE) -- The Board of Directors for Capital Power Corporation (“Capital Power”) (TSX: CPX) declared a dividend of $0.6910 per share on the outstanding common shares for the quarter ending September 30, 2025. The …

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution
WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician- …

Nick Stanage Joins HII Board of Directors
NEWPORT NEWS, Va., July 29, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that former chairman, CEO and president of Hexcel Corporation Nick Stanage was elected to the company’s board of directors. “We are pleased to welcome Nick to the board of …

Axonius Acquires Medical Device Security Specialist Cynerio for More Than $100 Million to Target Healthcare Market
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Axonius, the global leader in cyber asset intelligence, today announced that it has acquired Cynerio, a pioneer in medical device security for more than $100 million in a cash and stock transaction. The …

InterDigital and Samsung conclude arbitration and announce new license agreement
WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that its arbitration with Samsung Electronics has concluded and that the two …

Silvaco to Acquire Mixel, Inc. a Provider of Low-Power, High-Performance Mixed-Signal Connectivity IP Solutions
SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (“Silvaco”) (NASDAQ: SVCO), a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today …

100th Fisher House Dedicated at Lovell Federal Health Care Center
North Chicago, IL, July 29, 2025 (GLOBE NEWSWIRE) -- A new Fisher House was dedicated at the Captain James A. Lovell Federal Health Care Center (Lovell FHCC) by Lovell FHCC Director Dr. Robert Buckley, Deputy Director, Commanding Officer NMRTC Great Lakes …

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage …

DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation
Châtillon, France, le 29 juillet 2025 DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique …

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
DURHAM, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2025 …

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, …

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025
Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société biopharmaceutique …

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-to-treat population (N=110) – – Early PFS data show a trend favoring 30mg onvansertib dose arm vs. control arm – – Onvansertib …

Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference
REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Canaccord …